Amgen Chooses Freeslate as Strategic Partner for Protein Drug Product R&D
Freeslate, Inc., the leading provider of high throughput research solutions, announced today that Amgen, Inc. has entered into a collaborative relationship with the company to leverage Freeslate solutions in addressing aggregation and particulation in protein drug products. he multi-year project will utilize a range of Freeslate products and services, including technology development, high throughput microscale workflows, and Freeslate’s Lab Execution and Analysis (LEA) software.
to read the entire article. Please